Qube Research & Technologies (QRT)’s Evolent Health EVH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.27M	Buy	557,830 +383,802	+221%	+$1.22M	﹤0.01%	2386
2025 Q4	$696K	Buy	+174,028	New	+$967K	﹤0.01%	2704
2024 Q3	–	Sell	-638,164	Closed	-$12.2M	–	3525
2024 Q2	$12.2M	Buy	638,164 +532,474	+504%	+$13.6M	0.02%	823
2024 Q1	$3.47M	Buy	105,690 +91,123	+626%	+$2.91M	0.01%	1432
2023 Q4	$481K	Buy	+14,567	New	+$412K	﹤0.01%	2310
2022 Q4	–	Sell	-81,883	Closed	-$2.94M	–	2612
2022 Q3	$2.94M	Buy	+81,883	New	+$2.88M	0.02%	787
2022 Q2	–	Sell	-33,974	Closed	-$1.1M	–	2661
2022 Q1	$1.1M	Buy	33,974 +15,840	+87%	+$415K	0.01%	1128
2021 Q4	$502K	Buy	+18,134	New	+$520K	﹤0.01%	1566

Other funds holding EVH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVH Position: Q1 2026 in Review

Qube Research & Technologies (QRT) increased its Evolent Health (EVH) stake by 221% in Q1 2026, buying an estimated $1.22M and bringing the position to 557,830 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2386.

Qube Research & Technologies (QRT) first reported a position in EVH in Q4 2021 and has held it in 8 quarters since. The position peaked at $12.2M in Q2 2024. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

Qube Research & Technologies (QRT) held 557,830 shares of Evolent Health worth $1.27M as of Q1 2026.
Qube Research & Technologies (QRT) bought 383,802 Evolent Health shares in Q1 2026, an estimated $1.22M.
Evolent Health made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2386 holding.
Qube Research & Technologies (QRT) first reported a position in Evolent Health in Q4 2021 and has held it in 8 quarters since.
Qube Research & Technologies (QRT)'s Evolent Health position peaked at $12.2M in Q2 2024.
191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.